# Queue Patentability Review 2026: 6 Actors — Patentable or Reject?

Samantha Dixon · October 20, 2026

> Assess 2026 patentability for six filer types, from inventors to AI startups, and learn to frame technical processes and effects to avoid Section 3(m) rejections.

| Takeaway | Detail |
| --- | --- |
| Classify the filer into one of six actor types: lone inventor, university lab, software startup, AI/ML model builder, business-method filer, or process/industrial innovator. | Run this actor-type triage before filing; the six types are the guide’s recurring 2026 review categories. |
| Test whether the claim recites a technical process, not merely an abstract idea. | The threshold is a claim centered on a technical process with a disclosed technical effect; Section 3(m) is the stated distinction. |
| Do not treat novelty or an innovation alone as sufficient for patentability. | The decisive review question is whether the claim recites a technical process with a disclosed technical effect, rather than novelty alone. |
| Check the complete patentability requirements before filing a business-method claim. | Business methods are generally eligible for patent protection only if they pass the applicable patentability tests, including eligibility for patentable subject matter. |

This guide organizes 2026 patentability review around six recurring actor types, from lone inventors to AI/ML model builders and business-method filers. It provides a pre-filing triage focused on the controlling question: whether the claim recites a technical process with a disclosed technical effect.

![Queue Patentability Review 2026](https://static.mm-ais.com/article-images-ai/queue-patentability-review-2026-6-actors-ai-1b06a4fa.jpg)

## How patentability review actually works

Patentability review in 2026 works as a sequence of four gates, not as a single novelty test. As the Wikipedia business-method patent summary explains, the general framework asks, in order, whether the claimed invention is patentable subject matter, novel, inventive or non-obvious, and capable of industrial application, also described as utility. Each gate has a different question. Subject matter asks what kind of invention is being claimed; novelty asks whether the claimed combination is new; non-obviousness asks whether a skilled person could have derived it from the prior art; and utility asks whether the claimed invention has a specified, credible use. Passing the first gate does not eliminate the other three. Review should therefore record a separate result and basis for each test rather than treating “technical” as a substitute for the full analysis.

The first gate may be the most consequential for actor-specific review because a claim can fail there before novelty is reached. MPEP 2125.01 gives a concrete exclusion: “a new mineral discovered in the earth or new plant found in the wild is not patentable subject matter.” The disclosed discovery by itself is not converted into eligible subject matter merely because it is new. The practical check is to identify the claim’s operative contribution: a natural discovery, an abstract rule, or a technical process? If the claim merely characterizes a result found in nature, the subject-matter inquiry supplies the warning; if the claim recites a process using technical means to produce a technical effect, the analysis proceeds to the remaining gates.

Section 3(m) of the Indian Patents Act provides a related statutory hook in the SpicyIP commentary on *Beyond Abstract Ideas*. The commentary reports that the High Court distinguished abstract ideas from patentable technical processes by examining the process actually claimed, rather than looking only at the commercial outcome or the field in which it is used. For review purposes, the check is concrete: what steps does the claim require, what physical or computational mechanism performs them, and what technical effect follows? A business objective, user convenience, or data-processing instruction alone does not answer that question. A disclosed technical process with a stated technical effect creates a better-supported path through the subject-matter gate, but it still must satisfy novelty, non-obviousness, and utility.

The actor-type triage is the mechanism that organizes this review. Before filing, match the invention to the relevant recurring actor type: lone inventor, university lab, software startup, AI/ML model builder, business-method filer, or process/industrial innovator. Then map the claim to the actor’s disclosed technical process and technical effect, test that process against the first gate, and continue through novelty, inventive step, and utility in sequence. The actor label does not predetermine the outcome; it tells the reviewer where to inspect the specification for the process, mechanism, and effect that the claim must contain. Record the identified actor type, the claim’s core contribution, the subject-matter basis, and the result of each remaining gate. That record exposes whether a weakness is an eligibility problem, a prior-art problem, an obviousness problem, or an unsupported-utility problem—and keeps the later decision tied to the claim rather than to the applicant’s identity.

![How patentability review actually works — Queue Patentability Review 2026](https://static.mm-ais.com/article-images-ai/queue-patentability-review-2026-6-actors-ai-5a5c948d.jpg)

## The evidence: what the sources converge

The sources converge on a single point: subject-matter eligibility is not resolved by attaching a technical label to an otherwise abstract result. The inquiry must examine the claimed process itself, including the disclosed mechanism and the technical effect that flows from that mechanism. Novelty may remain an important later question, but it cannot rescue a claim whose core is outside the eligible subject matter described by the source material.

SpicyIP’s discussion of *Beyond Abstract Ideas* makes that distinction explicit. It reports the High Court’s observation that a Patent Office analysis under Section 3(m) is legally incorrect if the examiner stops at the conclusion that an invention is an “abstract idea” without examining the technical process disclosed in the specification. The practical review rule is therefore demanding: identify the concrete steps in the claim, trace their operation, and verify that the specification states a resulting technical effect. Merely reciting that software, an algorithm, or a model is involved does not complete that examination.

The MPEP’s patentable-subject-matter guidance marks the opposite boundary. Under its natural-discovery examples, a newly found mineral or a plant found in the wild is not patentable subject matter. This categorical exclusion is the hardest edge of the eligibility gate and is easily misapplied to process claims. A claim involving a natural material is not automatically ineligible because the material occurs in nature; the review must ask whether the claim instead recites an eligible human-made technical process that changes, conditions, or uses the material in a disclosed technical way. The distinction is between claiming the natural substance itself and claiming a technically defined operation involving it.

Wikipedia’s business-method patent summary supplies the broader procedural context: eligibility is a threshold that must be satisfied before an invention can receive patent protection, rather than a substitute answer supplied by later patentability considerations. The evidence can be reduced to a convergence table that turns the named authorities into drafting checks:

| Source | Convergent proposition | Pre-filing check |
| --- | --- | --- |
| SpicyIP, Beyond Abstract Ideas | A Section 3(m) rejection cannot stop at the label “abstract idea.” | Map each claim limitation to a disclosed technical process and technical effect. |
| USPTO MPEP | Naturally occurring minerals and wild plants are categorically excluded as claimed discoveries. | Distinguish a claim to the natural entity from a claim to a technical process that transforms, conditions, or uses it. |
| Wikipedia, business-method patent summary | Subject-matter eligibility is a threshold to patent protection. | Test the claim’s core before investing in novelty, non-obviousness, and drafting refinements. |

Applied to a draft claim, the check is concrete. First, list the steps that perform the work. Second, identify what those steps physically, computationally, or otherwise change. Third, locate the specification passage explaining the technical effect. Fourth, remove any limitation that exists only to characterize the activity at a high level of abstraction. If those steps reveal only a rule, business objective, or desired commercial outcome, the claim still lacks the technical process that SpicyIP says the eligibility analysis must examine; if they reveal a disclosed technical operation, the MPEP’s natural-discovery exclusion does not by itself dispose of the claim.

![The evidence: what the sources converge — Queue Patentability Review 2026](https://static.mm-ais.com/article-images-pixabay/queue-patentability-review-2026-6-actors-5d434b73.jpg)

## Six actors compared: who passes, who fails

Actor identity does not decide patentability, but it does predict which weakness is most likely to sink the application. The practical triage is to match the invention to one of six recurring actor types, identify that type’s dominant gate, and then test whether the claim recites a concrete technical process supported by a disclosed technical effect. As the SpicyIP analysis of patent eligibility emphasizes, describing an abstract result as “technical” does not transform it into a patentable technical process; the claimed mechanism and effect must do that work.

| Actor type | Dominant gate | Passing case | Failing case |
| --- | --- | --- | --- |
| Lone inventor | Novelty | A pre-filing patentability search identifies the closest prior art and supports a genuinely new claim. | The idea exists only in words, without drawings, a working model, or a prototype. |
| University lab | Subject matter plus the publication clock | The specification discloses a specific technical process and its technical effect before publication jeopardizes novelty. | The disclosure presents only an abstract research result, and the filing follows publication or other public disclosure. |
| Software startup | Subject matter | The claim is directed to a computer-implemented technical process whose operation produces a disclosed technical effect. | The claim merely applies software to a business or commercial objective without tying the claim to a technical improvement. |
| AI/ML model builder | Technical disclosure | The specification explains the model architecture, training or inference process, inputs, outputs, and resulting technical effect. | The application claims an abstract prediction or optimization result without disclosing how the claimed process achieves it. |
| Business-method filer | Subject matter | The claim recites a technical process and states a technical effect arising from that process. | The claim is organized around a business rule, commercial transaction, or organizational method. |
| Process/industrial innovator | Novelty and non-obviousness | The new process, its operating steps, and its technical effect are disclosed in enough detail to distinguish the invention from the prior art. | The specification supplies only a desired result or routine arrangement that a skilled person could readily derive. |

The lone inventor is especially exposed to a search-quality problem. The Ask Patents discussion expressly raises the situation in which an inventor has no drawings, models, prototypes, or blueprints and asks whether an idea described in words is patentable. The useful check is not whether the idea can be explained clearly; it is whether the file reveals enough structure to search meaningfully and draft claims supported by the description.

For a university lab, the timing check should accompany the technicality check. A technically implemented invention can still lose novelty if it has already been published or otherwise disclosed, while a prompt filing does not rescue a claim to an abstract research finding. The specification should therefore identify the process steps, equipment or system interaction, and technical effect—not merely state that the research produced a surprising result.

Among the six archetypes, the process/industrial innovator is the strongest overall candidate because the claimed invention is most likely to be the technical process itself. The remaining types can also pass, but only after their claims are narrowed to that same structure. A startup’s software, a lab’s model, or a filer’s workflow does not win through labels or commercial value; it wins when the claim shows a defined process and a technical effect produced by that process.

![Six actors compared: who passes, who fails — Queue Patentability Review 2026](https://static.mm-ais.com/article-images-pixabay/queue-patentability-review-2026-6-actors-7156dfe7.jpg)

## Costs and numbers that matter

The cost of being wrong on subject matter is the most structural: a full prosecution cycle may be spent on a claim that amendment cannot repair if the specification never disclosed the technical effect. The specification is the ceiling. A later argument cannot supply a missing mechanism that was not described when the application was filed. The USPTO’s patentable-subject-matter materials and the SpicyIP discussion of Section 3(m) both frame eligibility as turning on the claimed invention itself, not on the applicant’s intent or a label such as “technical.” Before filing, test whether the specification expressly discloses how the claimed process operates and what technical effect it produces.

The cost of being wrong on novelty is narrower. If a prior-art reference anticipates the claim, amendment may permit a narrower distinction when the original disclosure supports it. The checkpoint is not simply whether a reference exists, but whether the application already contains the features needed to claim over it. AnalystIP describes patentability review as a process for understanding the invention and comparing it with existing art; that comparison should occur before drafting, when claim scope can still be informed by the technical disclosure rather than locked into by an unsupported distinction.

The cost of being wrong on sufficiency is the worst because the gap affects what the application can support at all. If the specification does not enable the claim, the examiner may find that the claimed scope is not described in enough detail for a skilled person to practice the invention. Added language will not cure that defect without adding disclosure. The relevant check is practical: can a person skilled in the relevant field carry out the claimed steps using the written description, and do the described steps support the technical effect on which eligibility depends?

Use a search-before-draft checkpoint. First, identify the broad technical process and the disclosed technical effect. Second, search the relevant prior art, including references that could support an anticipation or obviousness position. Third, compare the prospective claim against both the references and the specification’s actual disclosure. Fourth, narrow the claim only to features already described. This sequence prevents a claim from outrunning either the prior art or the application’s disclosure.

Finally, keep the numbers attached to the right decisions. The business-method patent summary identifies patentable subject matter, novelty, inventive step or non-obviousness, and industrial applicability or utility as distinct requirements, so a resolution at one gate does not validate the others. The financial consequence of error therefore differs by gate: subject-matter error can require a full cycle; novelty error may be addressable through supportable narrowing; sufficiency error can undermine the claim’s foundation. A focused pre-filing review should ask which error is most likely, whether the specification can support a remedy, and whether the search has been completed before the claim is drafted.

![Costs and numbers that matter — Queue Patentability Review 2026](https://static.mm-ais.com/article-images-pixabay/queue-patentability-review-2026-6-actors-d1a2ff73.jpg)

## What the evidence does NOT establish

The available sources do not establish a numerical threshold at which an abstract idea becomes a technical process. SpicyIP explains that distinction in conceptual terms, but it does not quantify it. The practical check is therefore claim-specific: identify what steps the claim actually recites, what mechanism performs those steps, what technical effect is disclosed, and how that effect is connected to the claimed process. A label such as “AI,” “software,” or “optimization” cannot substitute for that analysis. If the specification does not explain how the claimed process achieves the asserted technical result, the actor-type triage cannot cure the gap.

Nor do the sources establish that any one of the six actor types will always pass or always fail. A lone inventor may disclose a concrete technical process, while a software startup may describe a result in purely functional terms; a university laboratory may contribute a technically integrated invention, while an industrial innovator may claim only a conventional result. A business-method filer may also present a claim directed to a technical process. These are edge cases, not automatic outcomes. The triage identifies the gate that deserves the closest review for the particular filing, but the specification and claim determine whether that gate is satisfied.

Before filing, test for these breakdown cases: the actor type is ambiguous; the claim’s core shifts between a result and the process used to obtain it; the specification mentions a technical effect but does not disclose a corresponding mechanism; or the dominant concern depends on facts outside the application, such as a third-party system’s configuration. In each case, narrow the analysis to the asserted technical process and its disclosed technical effect, and identify any missing support before filing. If that support cannot be supplied, treat the actor-type classification as preliminary rather than predictive.

The sources also do not supply jurisdiction-specific filing fees, prosecution deadlines, or examination timelines. Those figures must be checked in the official rules and current fee schedules for the intended office rather than inferred from general patentability discussions. The AnalystIP discussion, published March 26, 2025, emphasizes learning about the proposed process and the relevant patentability requirements; the USPTO summary similarly treats patentable subject matter and the treatment of abstract ideas as distinct from merely being novel. Thus, the defensible pre-filing checkpoint is procedural: classify the actor type, test the claim against the specification, and separately verify every current filing requirement with the relevant patent office.

![trees nature queue forest path landscape](https://static.mm-ais.com/article-images-pixabay/queue-patentability-review-2026-6-actors-b82f99e5.jpg)
trees nature queue forest path landscape

## The AI/ML model builder

An AI/ML model builder enters the 2026 patentability triage with a model that predicts equipment failure from sensor data. A first-pass draft—“a machine learning model configured to predict equipment failure”—states the desired result but may not claim a patent-eligible technical process. The model’s mere use of machine learning does not cure that defect. As the SpicyIP analysis of Section 3(m) explains, eligibility turns on whether the claim recites a technical process rather than merely attaching a technical label to an abstract idea.

Checkpoint 1 is subject matter. In the specification, identify three linked elements: the model architecture, the sensor-data pipeline, and the technical effect on the equipment. The architecture should disclose how the model processes the relevant sensor inputs; the pipeline should show how those inputs are acquired, prepared, and supplied to the model; and the technical-effect discussion should connect the prediction to equipment operation. If the specification supplies none of this, the claim is not ready to rely on subject-matter eligibility. It should be redrafted around the disclosed technical process, including the data flow and its equipment-level effect, rather than around the abstract goal of predicting failure.

Checkpoint 2 is novelty. Run a patentability search before further drafting, using the equipment-failure prediction process—not merely the label “machine learning model”—as the search focus. AnalystIP describes patentability searching as understanding the process, meaning, and relevant prior art. Compare the prior art with the disclosed architecture and sensor-data pipeline, then ask whether the claim’s recited combination already appears in a single reference. If it does, revise the claim or identify a genuinely new implementation; if it does not, preserve the supporting disclosure in the specification and claims.

The next checkpoint is non-obviousness: examine whether the combination of the disclosed model architecture, sensor-data processing, and equipment-level technical effect would have been obvious to a person having ordinary skill in the art. The search must therefore test the interaction among those elements, not just whether a model that predicts equipment failure was known. Novelty asks whether the claimed process is already disclosed; non-obviousness asks whether the particular claimed arrangement is an obvious substitution or combination of known work.

Finally, confirm utility and industrial applicability against the actual equipment process. The model should have a disclosed, credible use when performed as claimed, rather than merely produce a data-science result. The drafting rule is simple: convert the outcome-centered formulation into a process-centered claim supported by the architecture, pipeline, and equipment effect, and use the patentability search to test the resulting process before filing.

## Decision rules for the six actors

Start by identifying the filer’s actor type, then apply the matching rule to the claim before drafting the specification. For a business-method filer, if the claim recites a commercial workflow using generic computer language, do not pursue a patent filing. Reframe the claim around a technical process with a disclosed technical effect, or preserve the workflow as a trade secret. This follows the distinction identified by SpicyIP: adding a technical label does not convert an abstract idea into a technical process.

For a software startup or AI/ML model builder, if the specification does not disclose the technical implementation, rewrite the specification before filing. The filing should explain how the claimed process operates, not merely state its commercial purpose or result. The original disclosure is the ceiling for the application: later papers cannot retroactively supply a missing implementation, even if the applicant later acquires that knowledge. The practical check is whether a reader could identify the operative components, their relationships, and the claimed technical effect from what the specification actually teaches.

For a university-lab actor, if the work is described mainly by its objective, dataset, or experimental result, do not file until the application identifies the technical mechanism that produces the result. Record the relevant laboratory procedures, processing steps, and measurable effect so the claim is tied to a process rather than to a desired outcome. A research result alone may establish what was achieved; it does not necessarily disclose an invention broad enough to support a patent claim.

For a lone inventor, if the explanation consists only of “use a computer to improve” or “optimize the process,” stop and rebuild the disclosure around concrete steps, inputs, processing operations, and outputs. Then test whether those steps are actually technical and whether the specification states the effect they produce. The check is not whether the words sound technical, but whether removing the recited mechanism would leave only an abstract instruction.

For a process or industrial innovator, if the claim merely names a desired product, throughput, cost reduction, or business outcome, narrow the claim to the technical process that achieves that result and disclose the relevant operating conditions. Conversely, if the process includes specific machinery, process controls, or measured physical effects, make those features central rather than treating them as optional implementation details. The governing rule for all six actors is the same: if the claim’s core is a technical process with a disclosed technical effect, continue the patentability review; if the core remains an abstract result or generic commercial instruction, do not file as presented.

## What to do next

| Step | Action | Why it matters |
| --- | --- | --- |
| 1 | Classify the filer as a lone inventor, university lab, software startup, AI/ML model builder, business-method filer, or process/industrial innovator before preparing the application. | The six actor types determine which part of the 2026 review applies to the proposed filing. |
| 2 | Identify the actor-specific review route for the classified filer and use the recurring 2026 review categories as the filing checklist. | Actor-type triage exposes requirements that may otherwise be missed before the application enters the patentability queue. |
| 3 | Read the intended claims as a whole and determine whether their core recites a technical process with a disclosed technical effect under Section 3(m), rather than an abstract idea expressed through generic computer language. | Novelty or innovation alone does not establish patentability; the claim’s technical substance is the decisive threshold. |
| 4 | If the claims are abstract, revise the specification to add a specific technical implementation that supports the claim’s core technical process and its technical effect. | A concrete implementation strengthens the application before filing instead of relying on prosecution to supply the missing substance. |
| 5 | If the invention is better protected through confidential operational know-how, keep it as a trade secret rather than filing the abstract version. | Not every valuable process belongs in a patent application; preserving secrecy can be the appropriate route for the disclosed subject matter. |
| 6 | Run a final pre-filing review covering the complete patentability requirements, including the actor-type match, Section 3(m) analysis, disclosed technical effect, and the final technical or trade-secret decision. | This final check prevents an unsupported abstract filing and confirms that the chosen protection route matches the 2026 review criteria. |

## Frequently Asked Questions

**Which six actor types are used to classify a filer during the pre-filing patentability triage?**

The six types are lone inventor, university lab, software startup, AI/ML model builder, business-method filer, and process/industrial innovator.

**What threshold must a claim meet to be patentable under the stated Section 3(m) distinction?**

The claim must be centered on a technical process with a disclosed technical effect rather than merely recite an abstract idea.

**Does a novel or innovative invention automatically qualify for patent protection?**

No, because novelty or innovation alone is not sufficient for patentability.

**When should a business-method filer check the complete patentability requirements?**

The complete requirements should be checked before filing the business-method claim.

**Are business-method claims generally eligible for patent protection without further testing?**

No, business methods are generally eligible only if they pass the applicable patentability tests, including eligibility for patentable subject matter.

**At what stage should an applicant classify the filer into one of the six actor types?**

The applicant should perform the actor-type triage before filing.

## Quick answers

| What six actor types are used to classify filers? | The six actor types are lone inventor, university lab, software startup, AI/ML model builder, business-method filer, or process/industrial innovator. |
| --- | --- |
| What should filers do before filing? | Run this actor-type triage before filing. |
| What is the threshold for patentability? | The threshold is a claim centered on a technical process with a disclosed technical effect; Section 3(m) is the stated distinction. |
| Is novelty alone sufficient for patentability? | No, novelty or an innovation alone is not sufficient for patentability. |
| What is the decisive question in a patentability review? | The decisive review question is whether the claim recites a technical process with a disclosed technical effect, rather than novelty alone. |

Also worth reading: **AI Patent Review Tools Transform Prior Art Search in 2026**: [AI Patent Review Tools Transform](https://patentreviewpro.com/blog/ai_patent_review_tools_transform_prior_art_search_in_2026.php) · **AI Patent Analysis Tools Achieve 94% Accuracy in Prior Art Searches, New USPTO Study Reveals**: [AI Patent Analysis Tools Achieve](https://patentreviewpro.com/blog/ai_patent_analysis_tools_achieve_94_accuracy_in_prior_art_s.php) · **Avoiding Rejection How To Master Prior Art Research**: [Avoiding Rejection How To Master](https://patentreviewpro.com/blog/avoiding-rejection-how-to-master-prior-art-research.php)

### Related reading

- [The Evolving Landscape of Software Patentability Key Considerations for Inventors in 2024](https://patentreviewpro.com/blog/the_evolving_landscape_of_software_patentability_key_conside.php)
- [Mexico divisional timing: 30-day LFPPI Article 92 claim — how to verify before filing](https://patentreviewpro.com/blog/mexico-divisional-timing-30-day-lfppi-article-92-claim-how-to-verify-before-filing.php)
- [How to verify N.D. Cal. PTAB appeal win rates for Berkeley software patents, 2019–2024](https://patentreviewpro.com/blog/how-to-verify-nd-cal-ptab-appeal-win-rates-for-berkeley-software-patents-20192024.php)
- [Sisvel Hires McCurdy to Lead Proposed Patent Licensing Lab: 2026 SEP Rate Impact](https://patentreviewpro.com/blog/sisvel-hires-mccurdy-to-lead-proposed-patent-licensing-lab-2026-sep-rate-impact.php)
- [Trade Secret Protection: 4-Step Invention-Disclosure Screen Under the DTSA](https://patentreviewpro.com/blog/trade-secret-protection-4-step-invention-disclosure-screen-under-the-dtsa.php)
- [When to Narrow a Machine-Learning Patent Claim Under USPTO AI Guidance](https://patentreviewpro.com/blog/when-to-narrow-a-machine-learning-patent-claim-under-uspto-ai-guidance.php)

### Latest

- [Mexico divisional timing: 30-day LFPPI Article 92 claim — how to verify before...](https://patentreviewpro.com/blog/mexico-divisional-timing-30-day-lfppi-article-92-claim-how-to-verify-before-filing.php)
- [How to verify N.D. Cal. PTAB appeal win rates for Berkeley software patents,...](https://patentreviewpro.com/blog/how-to-verify-nd-cal-ptab-appeal-win-rates-for-berkeley-software-patents-20192024.php)
- [Sisvel Hires McCurdy to Lead Proposed Patent Licensing Lab: 2026 SEP Rate Impact](https://patentreviewpro.com/blog/sisvel-hires-mccurdy-to-lead-proposed-patent-licensing-lab-2026-sep-rate-impact.php)

Canonical: https://patentreviewpro.com/blog/queue-patentability-review-2026-6-actors-patentable-or-reject.php
Markdown: https://patentreviewpro.com/blog/queue-patentability-review-2026-6-actors-patentable-or-reject.php/index.md